Atanas G. Atanasov: Digital Health Expertise, Scientific Advisory & Global Keynote Speaking

Digital Health Technologies Expert | Scientific Credibility Evaluator | Research & Innovation Strategist | Editor-in-Chief | International Keynote Speaker

Atanas G. Atanasov is Chair of Pharmacology and Research Leader at the Patient Safety & Digital Health (PaDiH) Group at Danube Private University and the Ludwig Boltzmann Institute Digital Health and Patient Safety (LBI-DHPS), Medical University of Vienna. He serves as Professor at IGAB PAS, Honorary Fellow of the International Lipid Expert Panel (ILEP) and Saveetha Institute of Medical and Technical Sciences (SIMATS), and Editor-in-Chief of multiple international scientific journals.

He is internationally recognized for expertise in:

  • Digital health technologies and healthcare innovation
  • Scientific credibility evaluation and evidence appraisal
  • Translational molecular medicine and pharmacology
  • Biotechnology and innovation strategy
  • Research funding evaluation and expert peer review
  • Evidence synthesis and scientific substantiation
  • Stakeholder engagement in health innovation ecosystems
  • Strategic science communication and thought leadership

With more than 350 peer-reviewed publications and recognition as a Clarivate Cross-Field Highly Cited Researcher (2021–2023) and among the World’s Top 2% Scientists (Stanford/Elsevier/Scopus data), Dr. Atanasov combines deep methodological expertise with cross-sector innovation leadership.


Digital Health & Innovation Expertise

Dr. Atanasov works at the intersection of:

  • Digital health platforms
  • Health data–driven innovation
  • Translational biotechnology
  • Evidence-based health technologies
  • Research-to-application strategy

His expertise includes:

  • Evaluation of scientific credibility and robustness of clinical and preclinical evidence
  • Assessment of innovation maturity and translational readiness
  • Competitive positioning of health technologies
  • Evidence-informed product and research strategy
  • Cross-disciplinary integration of molecular medicine and digital technologies

He is particularly sought for projects where strong scientific validation and innovation positioning are required.


Scientific Credibility Evaluation & Due Diligence

Dr. Atanasov contributes to scientific and clinical evaluation for investors, publishers, research organizations, and innovation-driven companies.

His advisory work includes:

  • Critical appraisal of scientific literature and health claims
  • Assessment of study design, methodology, and reproducibility
  • Evaluation of translational strength and evidence hierarchy
  • Scientific differentiation analysis in competitive fields
  • Preparation of expert reports and strategic evidence summaries

His approach combines academic rigor, editorial oversight experience, and real-world innovation insight.


Stakeholder Engagement & Innovation Ecosystems

Dr. Atanasov is experienced in mobilizing and connecting:

  • Researchers
  • Healthcare professionals
  • Biotechnology innovators
  • Digital health entrepreneurs
  • Publishers and editors
  • Innovation leaders

Through executive leadership in open innovation platforms and global professional communities, he supports:

  • Expert community building
  • Cross-sector collaboration
  • Knowledge translation for diverse audiences
  • Strategic visibility initiatives
  • Field development in emerging research domains

His work bridges academia, industry, and innovation networks at international scale.


Digital Visibility & Thought Leadership

Dr. Atanasov is a prominent voice in professional digital science communication, with a combined following exceeding 165,000 professionals across LinkedIn, X (formerly Twitter), and Bluesky.

His online engagement focuses on:

  • Digital health technologies
  • Scientific credibility and evidence evaluation
  • Innovation in biotechnology and molecular medicine
  • Research impact and visibility strategies
  • Responsible and accessible science communication

His digital presence supports:

  • Sponsored evidence-based educational collaborations
  • Science ambassador roles
  • Conference and event promotion partnerships
  • Professional newsletter and thought leadership initiatives

All collaborations are grounded in transparent, evidence-based communication.


Conference Keynotes & Expert Talks

Dr. Atanasov is an internationally invited keynote speaker, panelist, and moderator at conferences, innovation forums, and executive meetings.

His keynote themes include:

  • Digital health transformation
  • Scientific credibility in health innovation
  • Translational biotechnology and molecular medicine
  • Evidence-based product positioning
  • Research visibility and thought leadership
  • Innovation ecosystems in healthcare

He delivers structured, high-level, insight-driven presentations tailored to scientific, executive, and investor audiences.


Research Evaluation & Editorial Leadership

As Editor-in-Chief of multiple international journals, Dr. Atanasov provides:

  • Advanced peer-review leadership
  • Research quality and innovation assessment
  • Field positioning of emerging technologies
  • Strategic publication development
  • Reviewer and author network mobilization

He frequently contributes as:

  • External expert reviewer
  • Panel evaluator for competitive funding
  • Scientific assessor of digital health and biotechnology projects

Author

Dr. Atanasov is the author of Health Hacks That Work: 50 Practical, Evidence-Informed Ways to Support Better Health (2026), translating high-quality human research into accessible strategies for broader audiences.


Engagement & Collaboration

Dr. Atanasov engages selectively in:

  • Scientific advisory roles
  • Evidence evaluation and due diligence projects
  • Executive workshops and professional training
  • Sponsored educational partnerships
  • International keynote speaking
  • Research evaluation panels

His work integrates scientific depth, stakeholder engagement, innovation strategy, and international visibility.